Microbot Medical (MBOT)
(Delayed Data from NSDQ)
$0.88 USD
+0.02 (1.95%)
Updated Apr 26, 2024 03:54 PM ET
After-Market: $0.88 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum B VGM
Income Statements
Fiscal Year end for Microbot Medical Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 10 | 13 | 11 | 9 | 7 |
Income After Depreciation & Amortization | -10 | -13 | -11 | -9 | -7 |
Non-Operating Income | -1 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -11 | -13 | -11 | -9 | -7 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -11 | -13 | -11 | -9 | -7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -11 | -13 | -11 | -9 | -7 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -10 | -13 | -11 | -9 | -7 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -10 | -13 | -11 | -9 | -7 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.20 | 7.26 | 7.11 | 7.12 | 4.27 |
Diluted EPS Before Non-Recurring Items | -1.05 | -1.81 | -1.59 | -1.29 | -1.70 |
Diluted Net EPS (GAAP) | -1.05 | -1.81 | -1.59 | -1.29 | -1.70 |
Fiscal Year end for Microbot Medical Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.07 | 2.54 | 2.33 | 2.92 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.07 | -2.54 | -2.33 | -2.92 |
Non-Operating Income | NA | -1.09 | 0.10 | 0.04 | 0.07 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -3.15 | -2.45 | -2.29 | -2.85 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.15 | -2.45 | -2.29 | -2.85 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.15 | -2.45 | -2.29 | -2.85 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 10.20 | 11.71 | 9.20 | 8.01 |
Diluted EPS Before Non-Recurring Items | NA | -0.26 | -0.21 | -0.25 | -0.36 |
Diluted Net EPS (GAAP) | NA | -0.23 | -0.21 | -0.25 | -0.36 |